XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net income $ 396,133 $ 400,975
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation expense 315,743 282,060
Amortization of deferred financing costs 4,042 3,873
Amortization of debt discount (premium) 849 (6,454)
Loss on extinguishment of debt, net 1,039 24,162
Amortization of stock-based compensation 10,127 9,658
Equity in loss (income) of, and return on, unconsolidated real estate entities and noncontrolling interests, net of eliminations 3,143 (4,473)
Casualty and impairment (gain) loss, net (58) 11,688
Abandonment of development pursuits 725 388
Cash flow hedge losses reclassified to earnings 3,213 3,534
Gain on sale of real estate assets (105,524) (141,079)
Increase in resident security deposits, prepaid expenses and other assets (3,875) (13,174)
(Decrease) increase in accrued expenses, other liabilities and accrued interest payable (260) 4,498
Net cash provided by operating activities 625,297 575,656
Cash flows from investing activities:    
Development/redevelopment of real estate assets including land acquisitions and deferred development costs (604,540) (495,868)
Capital expenditures - existing real estate assets (37,081) (22,415)
Capital expenditures - non-real estate assets (1,896) (6,334)
Proceeds from sale of real estate, net of selling costs 299,226 270,481
Insurance proceeds for property damage claims 58 6,192
Mortgage note receivable lending (2,291) (11,069)
Mortgage note receivable payment 27,511 0
Increase (decrease) in payables for construction 7,421 (6,463)
Distributions from unconsolidated real estate entities 2,013 21,852
Investments in unconsolidated real estate entities (7,102) (10,100)
Net cash used in investing activities (316,681) (253,724)
Cash flows from financing activities:    
Issuance of common stock, net 833 110,033
Dividends paid (399,070) (380,723)
Proceeds from Unsecured Lines of Credit 0 105,000
Proceeds from Notes Payable 0 185,100
Repayments of mortgage notes payable, including prepayment penalties (59,314) (1,287,048)
Issuance of unsecured notes 299,442 948,616
Payment of deferred financing costs (3,345) (11,466)
Payment of capital lease obligation (535) (18,422)
Receipts for termination of forward interest rate swaps 12,598 391
Payments related to tax withholding for share-based compensation (10,524) (10,441)
Distributions to DownREIT partnership unitholders (22) (21)
Contributions from joint venture and profit-sharing partners 0 1,038
Distributions to joint venture and profit-sharing partners (208) (213)
Preferred interest obligation redemption and dividends (480) (600)
Net cash used in financing activities (160,625) (358,756)
Net increase (decrease) in cash and cash equivalents 147,991 (36,824)
Cash and cash equivalents and restricted cash, beginning of period 201,906 329,977
Cash and cash equivalents and restricted cash, end of period 349,897 293,153
Cash paid during the period for interest, net of amount capitalized 95,204 102,624
Supplemental Cash Flow Information [Abstract]    
Cash, cash equivalents and restricted cash reported in the Condensed Consolidated Statements of Cash Flows $ 201,906 $ 329,977